DZ2854A1 - Dérivés de thiazolidinedione, compositions pharmaceutiques les contenant et leur utilisation. - Google Patents

Dérivés de thiazolidinedione, compositions pharmaceutiques les contenant et leur utilisation.

Info

Publication number: DZ2854A1
Authority: DZ; Algeria
Prior art keywords: pharmaceutical compositions; compositions containing; thiazolidinedione derivatives; thiazolidinedione; derivatives
Prior art date: 1998-07-21

Application number

DZ990154A

Other languages

English (en)

Inventor

Antoine Michel Alain Bril

Robin Edwin Buckingham

Nassirah Khandoudi

Original Assignee

Smithkline Beecham Lab

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-21

Filing date

1999-07-21

Publication date

2003-12-01

1998-07-21 Priority claimed from GBGB9815871.0A external-priority patent/GB9815871D0/en

1998-07-21 Priority claimed from GBGB9815872.8A external-priority patent/GB9815872D0/en

1999-07-21 Application filed by Smithkline Beecham Lab, Smithkline Beecham Plc filed Critical Smithkline Beecham Lab

2003-12-01 Application granted granted Critical

2003-12-01 Publication of DZ2854A1 publication Critical patent/DZ2854A1/fr

Links

239000008194 pharmaceutical composition Substances 0.000 title 1
150000001467 thiazolidinediones Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Thiazole And Isothizaole Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

DZ990154A 1998-07-21 1999-07-21 Dérivés de thiazolidinedione, compositions pharmaceutiques les contenant et leur utilisation. DZ2854A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9815871.0A GB9815871D0 (en)	1998-07-21	1998-07-21	Novel compound
GBGB9815872.8A GB9815872D0 (en)	1998-07-21	1998-07-21	Novel method

Publications (1)

Publication Number	Publication Date
DZ2854A1 true DZ2854A1 (fr)	2003-12-01

Family

ID=26314086

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ990154A DZ2854A1 (fr)	1998-07-21	1999-07-21	Dérivés de thiazolidinedione, compositions pharmaceutiques les contenant et leur utilisation.

Country Status (35)

Country	Link
EP (2)	EP1098638B1 (fr)
JP (1)	JP2002521325A (fr)
KR (1)	KR20010079550A (fr)
CN (1)	CN1167416C (fr)
AP (1)	AP1416A (fr)
AR (1)	AR020614A1 (fr)
AT (1)	ATE318588T1 (fr)
AU (1)	AU5053599A (fr)
BG (1)	BG105251A (fr)
BR (1)	BR9912144A (fr)
CA (1)	CA2338216A1 (fr)
CO (1)	CO5060465A1 (fr)
CY (1)	CY1106078T1 (fr)
CZ (1)	CZ2001250A3 (fr)
DE (1)	DE69930125T2 (fr)
DK (1)	DK1098638T3 (fr)
DZ (1)	DZ2854A1 (fr)
EA (1)	EA004772B1 (fr)
ES (1)	ES2259839T3 (fr)
GC (1)	GC0000173A (fr)
HU (1)	HUP0103870A3 (fr)
ID (1)	ID27850A (fr)
IL (1)	IL140741A0 (fr)
MA (1)	MA26662A1 (fr)
NO (1)	NO20010293L (fr)
NZ (1)	NZ509175A (fr)
OA (1)	OA11583A (fr)
PE (1)	PE20000881A1 (fr)
PL (1)	PL345663A1 (fr)
PT (1)	PT1098638E (fr)
SI (1)	SI1098638T1 (fr)
SK (1)	SK1022001A3 (fr)
TR (1)	TR200100208T2 (fr)
TW (2)	TWI239836B (fr)
WO (1)	WO2000004889A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6417212B1 (en)	1999-08-27	2002-07-09	Eli Lilly & Company	Modulators of peroxisome proliferator activated receptors
BR0017254A (pt) *	2000-06-16	2004-01-06	Smithkline Beecham Plc	Tratamento e prevenção de condições associadas à resistência cardìaca à insulina
JP4425628B2 (ja)	2001-07-23	2010-03-03	ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド	細胞保護化合物、薬学的処方物および美容用処方物、ならびに方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0842925A1 (fr) *	1987-09-04	1998-05-20	Beecham Group Plc	Thiazolidinédiones substituées
JPH05202042A (ja) *	1992-01-24	1993-08-10	Sankyo Co Ltd	糖尿病性合併症治療剤
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
GB9611947D0 (en) *	1996-06-07	1996-08-07	Glaxo Group Ltd	Medicaments
US6277819B1 (en) *	1996-08-30	2001-08-21	Eli Lilly And Company	Use of GLP-1 or analogs in treatment of myocardial infarction
ID21778A (id) *	1996-09-12	1999-07-22	Sankyo Co	Zat peningkat aktifitas glutation reduktase yang mengandung troglitazon
WO1999025346A1 (fr) *	1997-11-19	1999-05-27	Takeda Chemical Industries, Ltd.	Nouvel inhibiteur d'apoptose
AU2781899A (en) *	1998-02-24	1999-09-15	Trustees Of The University Of Pennsylvania, The	Use of a cardiac purinoceptor to effect cellular glucose uptake
WO1999059586A1 (fr) *	1998-05-19	1999-11-25	Regents Of The University Of California	Derives de thiazolidine et d'oxazolidine pour le traitement d'infarctus du myocarde aigus et pour l'inhibition de l'apoptose des cardiomyocytes
US5968960A (en) *	1999-01-14	1999-10-19	The Regents Of The University Of California	Use of thiazolidinediones to ameliorate the adverse consequences of myocardial ischemia on myocardial function and metabolism

1999
- 1999-07-19 MA MA25690A patent/MA26662A1/fr unknown
- 1999-07-20 PE PE1999000726A patent/PE20000881A1/es not_active Application Discontinuation
- 1999-07-21 DE DE69930125T patent/DE69930125T2/de not_active Expired - Fee Related
- 1999-07-21 JP JP2000560882A patent/JP2002521325A/ja not_active Withdrawn
- 1999-07-21 EP EP99934911A patent/EP1098638B1/fr not_active Expired - Lifetime
- 1999-07-21 GC GCP1999211 patent/GC0000173A/en active
- 1999-07-21 SI SI9930889T patent/SI1098638T1/sl unknown
- 1999-07-21 PL PL99345663A patent/PL345663A1/xx not_active Application Discontinuation
- 1999-07-21 TW TW088112356A patent/TWI239836B/zh not_active IP Right Cessation
- 1999-07-21 BR BR9912144-1A patent/BR9912144A/pt not_active IP Right Cessation
- 1999-07-21 CZ CZ2001250A patent/CZ2001250A3/cs unknown
- 1999-07-21 KR KR1020017000924A patent/KR20010079550A/ko not_active Ceased
- 1999-07-21 DK DK99934911T patent/DK1098638T3/da active
- 1999-07-21 PT PT99934911T patent/PT1098638E/pt unknown
- 1999-07-21 DZ DZ990154A patent/DZ2854A1/fr active
- 1999-07-21 OA OA1200100021A patent/OA11583A/en unknown
- 1999-07-21 HU HU0103870A patent/HUP0103870A3/hu unknown
- 1999-07-21 ID IDW20010151A patent/ID27850A/id unknown
- 1999-07-21 TR TR2001/00208T patent/TR200100208T2/xx unknown
- 1999-07-21 NZ NZ509175A patent/NZ509175A/en unknown
- 1999-07-21 CN CNB998089826A patent/CN1167416C/zh not_active Expired - Fee Related
- 1999-07-21 CO CO99045729A patent/CO5060465A1/es unknown
- 1999-07-21 WO PCT/GB1999/002358 patent/WO2000004889A1/fr not_active Ceased
- 1999-07-21 IL IL14074199A patent/IL140741A0/xx unknown
- 1999-07-21 AR ARP990103577A patent/AR020614A1/es not_active Application Discontinuation
- 1999-07-21 TW TW092103470A patent/TW200307532A/zh unknown
- 1999-07-21 AT AT99934911T patent/ATE318588T1/de not_active IP Right Cessation
- 1999-07-21 AU AU50535/99A patent/AU5053599A/en not_active Abandoned
- 1999-07-21 EP EP04077992A patent/EP1523980A3/fr not_active Withdrawn
- 1999-07-21 SK SK102-2001A patent/SK1022001A3/sk unknown
- 1999-07-21 ES ES99934911T patent/ES2259839T3/es not_active Expired - Lifetime
- 1999-07-21 CA CA002338216A patent/CA2338216A1/fr not_active Abandoned
- 1999-07-21 AP APAP/P/2001/002033A patent/AP1416A/en active
- 1999-07-21 EA EA200100164A patent/EA004772B1/ru not_active IP Right Cessation
2001
- 2001-01-18 NO NO20010293A patent/NO20010293L/no unknown
- 2001-02-14 BG BG105251A patent/BG105251A/xx unknown
2006
- 2006-05-12 CY CY20061100616T patent/CY1106078T1/el unknown

Also Published As

Publication number	Publication date
CZ2001250A3 (cs)	2002-03-13
NZ509175A (en)	2003-10-31
NO20010293D0 (no)	2001-01-18
KR20010079550A (ko)	2001-08-22
DE69930125T2 (de)	2006-10-05
CN1310619A (zh)	2001-08-29
BG105251A (en)	2001-10-31
ID27850A (id)	2001-04-26
TW200307532A (en)	2003-12-16
TR200100208T2 (tr)	2001-05-21
EA004772B1 (ru)	2004-08-26
CY1106078T1 (el)	2011-06-08
SI1098638T1 (sl)	2006-06-30
ES2259839T3 (es)	2006-10-16
EP1523980A3 (fr)	2009-03-18
HUP0103870A3 (en)	2003-06-30
EP1098638A1 (fr)	2001-05-16
AP2001002033A0 (en)	2001-03-31
AP1416A (en)	2005-06-13
BR9912144A (pt)	2001-04-03
PT1098638E (pt)	2006-07-31
ATE318588T1 (de)	2006-03-15
CO5060465A1 (es)	2001-07-30
CN1167416C (zh)	2004-09-22
EA200100164A1 (ru)	2001-08-27
NO20010293L (no)	2001-03-07
OA11583A (en)	2004-07-01
CA2338216A1 (fr)	2000-02-03
DE69930125D1 (de)	2006-04-27
PE20000881A1 (es)	2000-10-07
TWI239836B (en)	2005-09-21
SK1022001A3 (en)	2001-08-06
PL345663A1 (en)	2002-01-02
HUP0103870A2 (hu)	2002-05-29
EP1523980A2 (fr)	2005-04-20
EP1098638B1 (fr)	2006-03-01
GC0000173A (en)	2006-03-29
MA26662A1 (fr)	2004-12-20
AU5053599A (en)	2000-02-14
AR020614A1 (es)	2002-05-22
DK1098638T3 (da)	2006-06-19
IL140741A0 (en)	2002-02-10
WO2000004889A1 (fr)	2000-02-03
JP2002521325A (ja)	2002-07-16

Publication	Publication Date	Title
DZ2964A1 (fr)	2004-03-15	Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
DZ2594A1 (fr)	2003-02-22	Dérivés de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant.
DZ2887A1 (fr)	2003-12-15	Dérivés d'azétidine, leur préparation et les médicaments les contenant.
FR2708608B1 (fr)	1995-10-27	Dérivés de N-sulfonylbenzimidazolone, leur préparation, les compositions pharmaceutiques en contenant.
FR2732967B1 (fr)	1997-07-04	1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
DZ3191A1 (fr)	2001-01-11	Composés d'indazole et compositions pharmaceutiques inhibant les protéines kinases, et procédés d'utilisation de ceux-ci.
FR2708606B1 (fr)	1995-10-27	Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
DZ3326A1 (fr)	2005-05-29	Composés nouveaux modulateurs de chimiokine ccr5, et compositions pharmaceutiques les contenant.
DZ2614A1 (fr)	2003-03-01	Compositions pharmaceutiques topiques contenant des dérivés de résorcinol.
DZ2461A1 (fr)	2003-01-18	Dérivés d'arylkylamines nouveaux et composition pharmaceutiques les contenant.
MA26472A1 (fr)	2004-12-20	Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
HUP0203973A3 (en)	2004-07-28	Heterocyclic compounds having sulfonamide groups, pharmaceutical compositions containing them and their use
DZ2361A1 (fr)	2002-12-28	Dérivés de 6-phénylpyridyl-2-amine et compositionspharmaceutiques les contenant
BR9710372B1 (pt)	2013-02-05	composto, e, composiÇço farmacÊutica.
DZ1916A1 (fr)	2002-02-17	Composés nouveaux et compostions pharmaceutiques les contenant.
MA26490A1 (fr)	2004-12-20	Derives de tetrahydroisoquinoleine nouveaux, procedes pour leur preparation et compositions pharmaceutiques les contenant.
MA26443A1 (fr)	2004-12-20	Aralkyl- et aralkylidene-lactames et -imides heterocycliques, procedes pour leur preparation et compositions pharmaceutiques les contenant
FR2775596B1 (fr)	2004-12-24	Nouvelles compositions pharmaceutiques
MA26559A1 (fr)	2004-12-20	Derives de d-proline, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
MA26499A1 (fr)	2004-12-20	Derives de tetrazole, procede pour leur preparation et compositions pharmaceutiques les contenant .
EE03692B1 (et)	2002-04-15	19-nor-pregneeni derivaadid, mis omavad progestaatilist toimet ja neid sisaldavad farmatseutilised kompositsioonid
DZ2188A1 (fr)	2002-12-02	Dérivés de quinoxalinedone, procédés et intermédiaires pour leur préparation et compositions pharmaceutiques les contenant.
FR2700167B1 (fr)	1995-02-03	Dérivés de pyrrolidine et thiazolidine, leur préparation et les médicaments les contenant.
DZ2479A1 (fr)	2003-02-01	Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant.
ATE222897T1 (de)	2002-09-15	Substituierte thiazolidinedione derivate, ihre herstellung und pharmazeutische zusammensetzungen,die sie enthalten